Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists

3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists

US Patent 6903131 · Granted Jun 7, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic pantetheine derivatives and uses thereof2024
Pharmaceutical formulations that form gel in situ2023
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the2020
Substituted triazolo bicyclic compounds as PDE2 inhibitors2019
Bicyclic heterocyclic compounds as PDE2 inhibitors2019
Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors2019
Bicyclic aryl sphingosine 1-phosphate analogs2019
6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors2018
Piperazine derivatives as HIV protease inhibitors2018
Heterobicyclic sphingosine 1-phosphate analogs2018
ATX modulating agents2018
Compounds that are S1P modulating agents and/or ATX modulating agents2018